colforsin has been researched along with thiamylal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imanaga, K; Inoue, T; Ogawa, R; Ogura, A; Shiga, T; Wajima, Z; Yoshikawa, T | 1 |
| Hamada, H; Hidaka, I; Kawamoto, M; Kurokawa, H; Yasuda, T; Yuge, O | 1 |
1 trial(s) available for colforsin and thiamylal
| Article | Year |
|---|---|
Intravenous colforsin daropate, a water-soluble forskolin derivative, prevents thiamylal-fentanyl-induced bronchoconstriction in humans.
Topics: Adult; Airway Resistance; Anesthesia, Intravenous; Anesthetics, Intravenous; Bronchoconstriction; Bronchodilator Agents; Colforsin; Female; Fentanyl; Hemodynamics; Humans; Infusions, Intravenous; Lung Compliance; Male; Prospective Studies; Thiamylal | 2002 |
1 other study(ies) available for colforsin and thiamylal
| Article | Year |
|---|---|
Thiamylal and thiopental attenuate beta-adrenergic signaling pathway by suppressing adenylyl cyclase in rat ventricular myocytes.
Topics: Adenylyl Cyclase Inhibitors; Animals; Colforsin; Heart Ventricles; Humans; Hypnotics and Sedatives; Isoproterenol; Male; Myocytes, Cardiac; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Signal Transduction; Thiamylal; Thiopental | 2009 |